^Reverse sequential regimen: In women with
hirsutism, cyproterone acetate 100 mg/day from days 5 to 14 of the menstrual cycle and
ethinylestradiol 50 μg/day from days 5 to 25 of the cycle.
^Diane: In women with hirsutism, cyproterone acetate 2 mg/day and ethinylestradiol 50 μg/day from days 5 to 25 of the cycle.
This template can be used to easily insert a table detailing the side effects of estrogen plus high- versus low-dose cyproterone acetate in women into an article. It comes with five pre-provided references.
By passing the parameter |state=mw-collapsed, the table can be displayed as collapsed by default.
References
^Hammerstein, J. (1990). "Antiandrogens: Clinical Aspects". Hair and Hair Diseases. pp. 827–886.
doi:
10.1007/978-3-642-74612-3_35.
^Hammerstein J, Moltz L, Schwartz U (July 1983). "Antiandrogens in the treatment of acne and hirsutism". J. Steroid Biochem. 19 (1B): 591–7.
doi:
10.1016/0022-4731(83)90223-6.
PMID6224974.
^Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F (June 1975). "Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism". J. Steroid Biochem. 6 (6): 827–36.
doi:
10.1016/0022-4731(75)90311-8.
PMID126335.
^Moltz, L.; Meckies, J.; Hammerstein, J. (1979). "Die kontrazeptive Betreuung androgenisierter Frauen mit einem niedrig dosierten cyproteronacetathaltigen Einphasenpräparat" [The contraceptive care of androgenized women with a low-dose cyproterone acetate-containing single-phase preparation]. Deutsche Medizinische Wochenschrift. 104 (39): 1376–1382.
doi:
10.1055/s-0028-1129104.
ISSN0012-0472.